Skip to main content
. 2017 Aug 10;12(8):e0181603. doi: 10.1371/journal.pone.0181603

Table 2. Physician’s level of comfort managing and monitoring patients with liver disease.

Please rate your comfort level in initiating and monitoring hepatitis C treatment (n = 46)
Not comfortable 5 (10.9%)
Somewhat comfortable 7 (15.2%)
Neutral 13 (28.3%)
Comfortable 18 (39.1%)
Very comfortable 3 (6.5%)
Please rate your comfort level in monitoring hepatitis C patients not on treatment (n = 41)
Not comfortable 13 (31.7%)
Somewhat comfortable 9 (22.0%)
Neutral 8 (19.5%)
Comfortable 9 (22.0%)
Very comfortable 2 (4.9%)
Please rate your comfort level in monitoring hepatitis B patients not on treatment (n = 26)
Not comfortable 4 (15.4%)
Somewhat comfortable 4 (15.4%)
Neutral 9 (34.6%)
Comfortable 7 (26.9%)
Very comfortable 3 (7.7%)
Please rate your comfort level in initiating and monitoring hepatitis B treatment (n = 34)
Not comfortable 7 (20.6%)
Somewhat comfortable 5 (14.7%)
Neutral 10 (29.4%)
Comfortable 7 (20.6%)
Very comfortable 5 (14.7%)
Please rate your comfort level in providing medical therapy for HCC treatment (n = 40)
Not comfortable 14 (35.0%)
Somewhat comfortable 9 (22.5%)
Neutral 12 (30.0%)
Comfortable 4 (10.0%)
Very comfortable 1 (2.5%)
Please rate your comfort level in monitoring HIV/HCV co-infected patients (n = 44)
Not comfortable 8 (18.2%)
Somewhat comfortable 4 (9.1%)
Neutral 5 (11.4%)
Comfortable 23 (52.3%)
Very comfortable 4 (9.1%)
Please rate your comfort level in monitoring patients with cirrhosis (n = 35)
Not comfortable 2 (5.7%)
Somewhat comfortable 5 (14.3%)
Neutral 13 (37.1%)
Comfortable 13 (37.1%)
Very comfortable 2 (5.7%)
Please rate your comfort level in managing patients with ESLD (n = 40)
Not comfortable 16 (40.0%)
Somewhat comfortable 4 (10.0%)
Neutral 1 (27.5%)
Comfortable 8 (20.0%)
Very Comfortable 1 (2.5%)
Please rate your awareness of available HCV drugs (n = 47)
Not aware 4 (8.5%)
Somewhat aware 9 (19.2%)
Aware 24 (51.1%)
Very aware 10 (21.3%)